Business Context and Reporting Period
This Form 8-K is a current report filed by Xenomics, Inc. (not Cardiff Oncology, Inc., as indicated in the metadata) on April 5, 2007. The report discloses a change in the company's principal certifying accountant. The company is incorporated in Florida and maintains its principal executive offices in New York, New York.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report is strictly informational regarding a corporate governance event and does not contain financial performance data.
Material Changes
- Resignation of Prior Accountant: Lazar Levine & Felix LLP resigned as the Company's principal accountants on December 22, 2006.
- Appointment of New Accountant: On April 5, 2007, the Company engaged BDO Seidman, LLP as its new principal independent registered public accounting firm.
- Approval: The appointment was approved by the Company's audit committee.
Guidance, Outlook, and Risks
The filing does not contain guidance, outlook, or management commentary regarding future financial performance. Regarding the change in accountants, the Company stated that prior to engaging BDO Seidman, LLP:
- There were no consultations regarding the application of accounting principles to specified transactions or the type of audit opinion that might be rendered.
- There were no consultations regarding matters that were subjects of disagreement or reportable events as defined in Item 304(a)(1)(iv)(A) of Regulation S-K.
Important Facts for Investors to Verify
- Verify the reasons for the resignation of the previous auditor, Lazar Levine & Felix LLP, by reviewing the Form 8-K filed on December 28, 2006.
- Confirm the scope of the new engagement with BDO Seidman, LLP and any potential impact on the audit timeline for the fiscal year.
- Note the discrepancy between the metadata company name (Cardiff Oncology, Inc.) and the actual registrant in the filing (Xenomics, Inc.).